How much does Mounjaro cost at Boots?

What Boots charges for Mounjaro

Boots supplies Mounjaro through its Online Doctor service, with pricing tiered by dose strength across all six pens. As publicly listed in August 2026, that runs from roughly £179 a month for the 2.5mg starter dose up to around £339 a month at the top strengths — each pen covering four weekly doses, so the per-pen price is effectively the monthly price. Boots adjusted its pricing when manufacturer list prices changed in late 2025, publishing its own explainer at the time, so treat any figure — including ours — as a snapshot and confirm the current list before deciding.

Market comparisons in mid-2026 generally place Boots towards the upper end of UK pricing, commonly £30 to £100 a month above online specialists for the same pen at the same dose. That premium is not hidden — it is the price of the brand and the bricks-and-mortar network behind it.

What is included at Boots

What the Boots price buys, beyond the pen: an online clinical assessment through Boots Online Doctor, the backing of the UK's largest pharmacy chain, and the option to collect from a local Boots store rather than wait for delivery — genuinely useful for a refrigerated medicine if you are rarely home. Boots has also experimented with engagement-linked discounts (including a scheme rewarding activity tracked through its app), so promotional pricing appears periodically.

For many people the Boots premium is really a familiarity purchase: a household name, physical stores, and an established complaints and support infrastructure. Those are real features; whether they are worth £30 to £100 a month against an equally regulated online specialist is the genuine question to sit with.

The dose ladder is your real monthly cost

Whichever provider you choose, Mounjaro treatment climbs a ladder: it starts at 2.5mg weekly and steps up through 5mg, 7.5mg, 10mg and 12.5mg towards 15mg over months, with each step held until you and your prescriber judge it right to move. Pricing follows the ladder, which is why "from" prices describe a rung you occupy only briefly. A realistic budget takes Boots's price at the dose you are likely to maintain and multiplies it across a treatment horizon measured in months, not weeks. Two providers twenty pounds apart at the starter dose can be sixty pounds apart at maintenance; the ladder is where comparisons are won and lost.

Dose availability matters too: supply in this market has periodically tightened at specific strengths, and a provider's price is academic if your dose is out of stock the week you need to step up. It is a fair pre-sales question for any provider, Boots included: how has availability at each strength held up recently, and what happens to my treatment if my dose is unavailable?

How Boots compares with the wider market

For context, UK private Mounjaro pricing in mid-2026 spans roughly £130 to £350 a month across regulated providers, with the spread driven by dose strength, what is bundled (consultations, needles, sharps disposal, delivery, support), and brand positioning — the mechanics we unpack in our guide to why Mounjaro prices vary between UK pharmacies. Where Boots sits in that range matters less than whether its particular bundle matches what you will actually use: a premium you never draw on is waste, and a bare price that forces add-on fees is a mirage.

Remember also that the NHS route exists for those who qualify — our guide to NHS eligibility covers it — and that every regulated provider, Boots included, is dispensing the identical licensed pen. You are comparing services, never medicines.

The 2026 backdrop deserves a sentence: manufacturer list-price changes in late 2025 rippled through every UK provider, repricing the whole market within weeks and reshuffling who stood where. Comparison content written before that repricing is still ranking all over the web, describing a market that no longer exists. It will happen again, in either direction; date-check anything you read, including us.

What to check before you decide

Five checks produce a fair comparison with any provider: the standard price at every dose strength (not the promotional entry price); what consultations and reviews cost, if anything; whether needles, sharps disposal and refrigerated delivery are included; the subscription terms — renewal, pause, cancellation; and the provider's GPhC registration, checkable at pharmacyregulation.org. If you are switching providers mid-treatment, add one more: continuity — your current dose and titration history should transfer cleanly, so ask how the new prescriber handles it.

Then check what a price list cannot show. How quickly does the service respond when you report side effects: hours or days? Are dose reviews conducted by a clinician or a form? If a refrigerated delivery fails, whose problem is it and how fast is it fixed? The answers separate services that manage treatment from services that ship it, and they are discoverable before you commit: reviews, response times to your own pre-sales questions, and how clearly the provider explains its processes are all evidence. Treatment in this class typically runs many months; you are choosing a working relationship, not a parcel.

Putting it together: a realistic first-year budget

Here is the arithmetic worth doing before committing to Boots or anyone else. Sketch a plausible year: a month or two at the starter dose, a stepped climb through the middle strengths, then the rest of the year at your maintenance dose. Price each phase from the provider's standard dose-tier list, add any consultation or review fees and delivery charges the bundle excludes, and subtract nothing for promotional first months unless the terms are in writing. The total will usually land somewhere in the low-to-mid four figures for a full year of private treatment — a number worth seeing clearly at the start, because treatment abandoned early for budget reasons is the most expensive outcome of all.

Run the same sum for two or three providers and the comparison becomes strikingly concrete. It also reframes the decision usefully: at a year's horizon, a genuinely supportive service that keeps you on treatment comfortably is worth more than a marginal monthly saving from one that leaves you managing side effects alone. Cheap treatment you stop is dearer than fair-priced treatment you finish.

Where Farmeci fits

We would rather earn the comparison than dodge it. Farmeci is a GPhC-registered UK pharmacy offering medically supervised weight-management treatment with a free, no-obligation clinician consultation first — eligibility and suitability before any money changes hands — followed by transparent dose-tier pricing and pharmacist support through titration, side effects and reviews. Current prices are always on our clinic pages, dated and inclusive of what they say they include.

Put us in your comparison table alongside Boots and judge on the same five checks above. The consultation costs nothing either way — and it answers the question every price list skips: whether this treatment is right for you at all. Our weight-management guides are there to make that decision an informed one, wherever you end up being treated.